Skip to main content
PACB
NASDAQ Life Sciences

PacBio Q2 Loss Wider Than Expected, Revenue Misses; Guides 2026 Revenue Below Street

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.25
Mkt Cap
$403.782M
52W Low
$1.09
52W High
$2.73
52W Position info
15% above low
Off High info
54% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

PACB is trading near its 52-week low of $1.09 (15% above the low).

Summary

PacBio's Q2 revenue fell to $39M, missing the $40.07M consensus, while adjusted loss per share of $0.14 was a penny worse than expected. Gross margin compressed to 36% on higher compute costs and lower Revio ASPs from strategic multi-system placements. The company guided full-year 2026 revenue to $155M-$165M, well below the $180M+ Street was modeling. This follows today's earlier announcement of a CEO change and a $30M-$40M cost restructuring—the earnings miss and weak guide add urgency to that turnaround. With shares at $1.25 and a $404M market cap, the revenue trajectory and margin pressure raise serious questions about the Vega/SPRQ-Nx ramp delivering the promised second-half inflection.

Updates

  1. · Wiseek News — PacBio delayed cash-flow breakeven to 2028 and set non-GAAP gross margin of 35%-37%, operating expenses of $215M-$220M, and year-end cash of $175M-$185M.

At the time of this announcement, PACB was trading at $1.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $403.8M. The 52-week trading range was $1.09 to $2.73. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PACB - Latest Insights

PACB
Nov 10, 2026, 4:05 PM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $2.25
Real-time Price: $1.94 info
Change: -$0.309 (-14%) info
Market Cap: $606.17M info
PACB
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.54
Real-time Price: $1.94 info
Change: -$0.600 (-24%) info
Market Cap: $606.17M info
PACB
Nov 04, 2026, 5:41 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $1.94 info
Change: -$0.660 (-25%) info
Market Cap: $606.17M info
PACB
Nov 04, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $1.94 info
Change: -$0.740 (-28%) info
Market Cap: $606.17M info
PACB
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.57
Real-time Price: $1.94 info
Change: -$0.630 (-25%) info
Market Cap: $606.17M info